Application YC di zPREDICTA
zPREDICTA ha partecipato a Y Combinator nel batch Summer 2015 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.
- Batch YC
- Summer 2015
- Settore
- HealthcareDrug Discovery and Delivery
- Dimensione team
- 2
- Stato
- Acquired
- Lanciata
- 2015
Founder
Mukti ParikhFounder/CTO
Cosa fa zPREDICTA
zPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture approach that comprehensively accounts for the major components of the cellular and extracellular tissue microenvironment preserving the critical interactions between a tumor and its surroundings. Clinical study data demonstrate the high correlation between drug efficacy measured in our platform and the clinical response. The ability of the zPREDICTA platform to reliably predict clinical outcomes offers superior compound attrition management, empowering researchers to exclude ineffective compounds while selecting agents with a high probability of success in the clinic. Our approach is compatible with any drug class, multiple tissue/cell types and a wide variety of readouts. Our customers are using these models for efficacy screening of anticancer compounds, including immuno-oncology agents, evaluation of mechanisms of drug resistance, the rescue of failed drug candidates, assessment of off-target toxicity, and a multitude other applications.
Application YC di zPREDICTA, ricostruita
Domanda per Y Combinator
zPREDICTA, batch Summer 2015. Le vere domande del form, risposte da dati pubblici.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
zPREDICTA
Patient-derived 3D tissue models for drug testing
We build organ-specific, physiologically relevant 3D cell culture models that reconstruct human tissues on a 1-to-1 scale. Our platform preserves interactions between tumors and their microenvironment, offering a better way to predict drug responses before clinical trials. Researchers use our models to screen anticancer compounds, study drug resistance, and evaluate toxicity.
We live in San Jose, CA, and plan to keep the company based here after YC.
San Jose is where our labs and early operations are set up, and it's close to the biomedical ecosystem we rely on. Staying here means maintaining easy access to patient samples and collaborators.
21 risposte in più nell'application completa
Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.
Domande Frequenti
Questa è l'application YC reale di zPREDICTA?
No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di zPREDICTA (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come zPREDICTA si presenterebbe a YC, non il testo che hanno inviato.
A quale batch YC apparteneva zPREDICTA?
zPREDICTA apparteneva al batch Summer 2015 di Y Combinator.
Chi ha fondato zPREDICTA?
zPREDICTA è stato fondato da Mukti Parikh.
Cosa fa zPREDICTA?
Patient-derived 3D tissue reconstruction models for preclinical…
Come leggo la ricostruzione completa della application?
Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di zPREDICTA, e di ogni altro batch YC, è in YC Insights.
Più startup YC come zPREDICTA
